Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

It is time for the world to take COPD seriously: a statement from the GOLD board of directors.

Halpin DMG, Celli BR, Criner GJ, Frith P, López Varela MV, Salvi S, Vogelmeier CF, Chen R, Mortimer K, Montes de Oca M, Aisanov Z, Obaseki D, Decker R, Agusti A.

Eur Respir J. 2019 Jul 4;54(1). pii: 1900914. doi: 10.1183/13993003.00914-2019. Print 2019 Jul. No abstract available.

PMID:
31273036
2.

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019.

Singh D, Agusti A, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Criner GJ, Frith P, Halpin DMG, Han M, López Varela MV, Martinez F, Montes de Oca M, Papi A, Pavord ID, Roche N, Sin DD, Stockley R, Vestbo J, Wedzicha JA, Vogelmeier C.

Eur Respir J. 2019 May 18;53(5). pii: 1900164. doi: 10.1183/13993003.00164-2019. Print 2019 May. Review.

PMID:
30846476
3.

Current Controversies in Chronic Obstructive Pulmonary Disease. A Report from the Global Initiative for Chronic Obstructive Lung Disease Scientific Committee.

Criner GJ, Martinez FJ, Aaron S, Agusti A, Anzueto A, Bafadhel M, Barnes PJ, Bourbeau J, Chen R, Ewig J, Fabbri LM, Frith P, Halpin DMG, Han M, Montes de Oca M, Nishimura M, O'Donnell D, Papi A, Pavord I, Roche N, Rodriguez-Roisin R, Salvi S, Singh D, Sin DD, Stockley R, López Varela MV, Vestbo J, Vogelmeier CF, Washko G, Wedzicha JA, Celli BR.

Ann Am Thorac Soc. 2019 Jan;16(1):29-39. doi: 10.1513/AnnalsATS.201808-557PS. No abstract available.

PMID:
30427736
4.

Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study.

Casas A, Montes de Oca M, Menezes AM, Wehrmeister FC, Lopez Varela MV, Mendoza L, Ramírez L, Miravitlles M.

Int J Chron Obstruct Pulmon Dis. 2018 May 11;13:1545-1556. doi: 10.2147/COPD.S154097. eCollection 2018. Erratum in: Int J Chron Obstruct Pulmon Dis. 2019 Jan 18;14:241.

5.

Prevalence and impact of respiratory symptoms in a population of patients with COPD in Latin America: The LASSYC observational study.

Miravitlles M, Menezes A, López Varela MV, Casas A, Ugalde L, Ramirez-Venegas A, Mendoza L, López A, Wehrmeister FC, Surmont F, Montes de Oca M.

Respir Med. 2018 Jan;134:62-69. doi: 10.1016/j.rmed.2017.11.018. Epub 2017 Nov 28.

PMID:
29413510
6.

Adherence to inhaled therapies of COPD patients from seven Latin American countries: The LASSYC study.

Montes de Oca M, Menezes A, Wehrmeister FC, Lopez Varela MV, Casas A, Ugalde L, Ramirez-Venegas A, Mendoza L, López A, Surmont F, Miravitlles M.

PLoS One. 2017 Nov 15;12(11):e0186777. doi: 10.1371/journal.pone.0186777. eCollection 2017.

7.

Smoke, Biomass Exposure, and COPD Risk in the Primary Care Setting: The PUMA Study.

Montes de Oca M, Zabert G, Moreno D, Laucho-Contreras ME, Lopez Varela MV, Surmont F.

Respir Care. 2017 Aug;62(8):1058-1066. doi: 10.4187/respcare.05440. Epub 2017 May 30.

8.

Lung function decline in subjects with and without COPD in a population-based cohort in Latin-America.

Pérez-Padilla R, Fernandez-Plata R, Montes de Oca M, Lopez-Varela MV, Jardim JR, Muiño A, Valdivia G, Menezes AMB; PLATINO group.

PLoS One. 2017 May 4;12(5):e0177032. doi: 10.1371/journal.pone.0177032. eCollection 2017.

9.

Respiratory medication use in primary care among COPD subjects in four Latin American countries.

Jardim JR, Stirbulov R, Moreno D, Zabert G, Lopez-Varela MV, Montes de Oca M.

Int J Tuberc Lung Dis. 2017 Apr 1;21(4):458-465. doi: 10.5588/ijtld.16.0633.

PMID:
28284262
10.

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.

Vogelmeier CF, Criner GJ, Martínez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DM, López Varela MV, Nishimura M, Roche N, Rodríguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agustí A.

Arch Bronconeumol. 2017 Mar;53(3):128-149. doi: 10.1016/j.arbres.2017.02.001. Epub 2017 Mar 6. English, Spanish. Erratum in: Arch Bronconeumol. 2017 Jul;53(7):411-412.

11.

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.

Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DM, López Varela MV, Nishimura M, Roche N, Rodriguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agusti A.

Eur Respir J. 2017 Mar 6;49(3). pii: 1700214. doi: 10.1183/13993003.00214-2017. Print 2017 Mar. Erratum in: Eur Respir J. 2017 Jun 22;49(6):.

12.

Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.

Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DM, López Varela MV, Nishimura M, Roche N, Rodriguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agusti A.

Respirology. 2017 Apr;22(3):575-601. doi: 10.1111/resp.13012. Epub 2017 Mar 7.

13.

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.

Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DM, López Varela MV, Nishimura M, Roche N, Rodriguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agustí A.

Am J Respir Crit Care Med. 2017 Mar 1;195(5):557-582. doi: 10.1164/rccm.201701-0218PP.

14.

Exacerbations and health care resource utilization in patients with airflow limitation diseases attending a primary care setting: the PUMA study.

Montes de Oca M, Aguirre C, Lopez Varela MV, Laucho-Contreras ME, Casas A, Surmont F.

Int J Chron Obstruct Pulmon Dis. 2016 Dec 7;11:3059-3067. eCollection 2016.

15.

Classification of patients with chronic obstructive pulmonary disease according to the Latin American Thoracic Association (ALAT) staging systems and the global initiative for chronic obstructive pulmonary disease (GOLD).

Montes de Oca M, López Varela MV, Laucho-Contreras ME, Casas A, Schiavi E, Rey A, Silva A; en nombre del equipo del estudio PUMA.

Arch Bronconeumol. 2017 Mar;53(3):98-106. doi: 10.1016/j.arbres.2016.08.015. Epub 2016 Dec 10. English, Spanish.

16.

Development of a simple screening tool for opportunistic COPD case finding in primary care in Latin America: The PUMA study.

López Varela MV, Montes de Oca M, Rey A, Casas A, Stirbulov R, Di Boscio V; PUMA Team.

Respirology. 2016 Oct;21(7):1227-34. doi: 10.1111/resp.12834. Epub 2016 Jun 20.

PMID:
27319305
17.

Bronchodilator treatment for COPD in primary care of four Latin America countries: The multinational, cross-sectional, non-interventional PUMA study.

Montes de Oca M, Lopez Varela MV, Jardim J, Stirvulov R, Surmont F.

Pulm Pharmacol Ther. 2016 Jun;38:10-6. doi: 10.1016/j.pupt.2016.04.002. Epub 2016 Apr 23.

PMID:
27113029
18.

COPD Underdiagnosis and Misdiagnosis in a High-Risk Primary Care Population in Four Latin American Countries. A Key to Enhance Disease Diagnosis: The PUMA Study.

Casas Herrera A, Montes de Oca M, López Varela MV, Aguirre C, Schiavi E, Jardim JR; PUMA Team.

PLoS One. 2016 Apr 13;11(4):e0152266. doi: 10.1371/journal.pone.0152266. eCollection 2016.

19.

ALAT-2014 Chronic Obstructive Pulmonary Disease (COPD) Clinical Practice Guidelines: questions and answers.

Montes de Oca M, López Varela MV, Acuña A, Schiavi E, Rey MA, Jardim J, Casas A, Tokumoto A, Torres Duque CA, Ramírez-Venegas A, García G, Stirbulov R, Camelier A, Bergna M, Cohen M, Guzmán S, Sánchez E.

Arch Bronconeumol. 2015 Aug;51(8):403-16. doi: 10.1016/j.arbres.2014.11.017. Epub 2015 Jan 14. English, Spanish.

20.

FEV1 is a better predictor of mortality than FVC: the PLATINO cohort study.

Menezes AM, Pérez-Padilla R, Wehrmeister FC, Lopez-Varela MV, Muiño A, Valdivia G, Lisboa C, Jardim JR, de Oca MM, Talamo C, Bielemann R, Gazzotti M, Laurenti R, Celli B, Victora CG; PLATINO team.

PLoS One. 2014 Oct 6;9(10):e109732. doi: 10.1371/journal.pone.0109732. eCollection 2014.

21.

A population-based cohort study on chronic obstructive pulmonary disease in Latin America: methods and preliminary results. The PLATINO Study Phase II.

Menezes AM, Muiño A, López-Varela MV, Valdivia G, Lisboa C, Jardim JR, Montes de Oca M, Tálamo C, Wehrmeister FC, Perez-Padilla R; Equipo del estudio Platino.

Arch Bronconeumol. 2014 Jan;50(1):10-7. doi: 10.1016/j.arbres.2013.07.014. Epub 2013 Dec 12. English, Spanish.

22.

Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma.

Menezes AMB, Montes de Oca M, Pérez-Padilla R, Nadeau G, Wehrmeister FC, Lopez-Varela MV, Muiño A, Jardim JRB, Valdivia G, Tálamo C; PLATINO Team.

Chest. 2014 Feb;145(2):297-304. doi: 10.1378/chest.13-0622.

PMID:
24114498
23.

Reliability of FEV1/FEV6 to diagnose airflow obstruction compared with FEV1/FVC: the PLATINO longitudinal study.

Perez-Padilla R, Wehrmeister FC, Celli BR, Lopez-Varela MV, Montes de Oca M, Muiño A, Talamo C, Jardim JR, Valdivia G, Lisboa C, Menezes AM; PLATINO Team.

PLoS One. 2013 Aug 1;8(8):e67960. doi: 10.1371/journal.pone.0067960. Print 2013.

24.

Comorbidities and health status in individuals with and without COPD in five Latin American cities: the PLATINO study.

López Varela MV, Montes de Oca M, Halbert R, Muiño A, Tálamo C, Pérez-Padilla R, Jardim JR, Valdivia G, Pertuzé J, Menezes AM; PLATINO team.

Arch Bronconeumol. 2013 Nov;49(11):468-74. doi: 10.1016/j.arbres.2013.05.003. Epub 2013 Jul 13. English, Spanish.

25.

Perceptions of short and long sleep duration and comorbid conditions: the PLATINO study.

Torre-Bouscoulet L, Garcia Sancho C, Vázquez García JC, Salazar-Peña CM, Lopez Varela MV, de Oca MM, Muiño A, Tálamo C, Valdivia G, Menezes AM, Perez-Padilla R.

Sleep Med. 2013 Sep;14(9):850-7. doi: 10.1016/j.sleep.2013.04.014. Epub 2013 Jul 12.

PMID:
23856294
26.

Airflow obstruction in never smokers in five Latin American cities: the PLATINO study.

Perez-Padilla R, Fernandez R, Lopez Varela MV, Montes de Oca M, Muiño A, Tálamo C, Brito Jardim JR, Valdivia G, Baptista Menezes AM.

Arch Med Res. 2012 Feb;43(2):159-65. doi: 10.1016/j.arcmed.2012.03.007. Epub 2012 Apr 2.

PMID:
22475778
27.

Variability in COPD: the PLATINO study viewpoint.

López Varela MV, Montes de Oca M.

Arch Bronconeumol. 2012 Apr;48(4):105-6. doi: 10.1016/j.arbres.2011.09.007. Epub 2011 Dec 3. English, Spanish. No abstract available.

28.

Sex-related differences in COPD in five Latin American cities: the PLATINO study.

Lopez Varela MV, Montes de Oca M, Halbert RJ, Muiño A, Perez-Padilla R, Tálamo C, Jardim JR, Valdivia G, Pertuzé J, Moreno D, Menezes AM; PLATINO Team.

Eur Respir J. 2010 Nov;36(5):1034-41. doi: 10.1183/09031936.00165409. Epub 2010 Apr 8.

29.

[Treatment of chronic obstructive pulmonary disease in 5 Latin American cities: the PLATINO study].

López Varela MV, Muiño A, Pérez Padilla R, Jardim JR, Tálamo C, Montes de Oca M, Valdivia G, Pertuzé J, Halbert R, Menezes AM; PLATINO Group.

Arch Bronconeumol. 2008 Feb;44(2):58-64. Spanish.

30.

[Functional status and survival in patients with chronic obstructive pulmonary disease following pulmonary rehabilitation].

López Varela MV, Anido T, Larrosa M.

Arch Bronconeumol. 2006 Sep;42(9):434-9. Spanish.

Supplemental Content

Loading ...
Support Center